(Total Views: 113)
Posted On: 06/05/2018 12:13:43 PM
Post# of 74550
$MPHMF / $LILY:CSE
Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced that its Chief Medical Cannabis Advisor Dr. Gregory Smith MD, MPH has released a new book. Aimed at patients and caregivers, “CBDPlus” explores the cannabinoid tetrahydrocannabivarin (THCV) For More Information: http://www.thestreetnow.com/spotlight/mphmf/
Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced that its Chief Medical Cannabis Advisor Dr. Gregory Smith MD, MPH has released a new book. Aimed at patients and caregivers, “CBDPlus” explores the cannabinoid tetrahydrocannabivarin (THCV) For More Information: http://www.thestreetnow.com/spotlight/mphmf/
(0)
(0)
